Your browser doesn't support javascript.
Antibody response to COVID-19 mRNA vaccine (Comirnaty) in myeloma patients treated with high-dose melphalan and/or immunotherapy.
Lockmer, Sandra; Uttervall, Katarina; Kashif, Muhammad; Svärd, Carina; Malmsten, Katarina; Fletcher-Torres, Evellyn; Alici, Evren; Lund, Johan; Nahi, Hareth.
  • Lockmer S; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Uttervall K; Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Kashif M; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Svärd C; Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Malmsten K; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Fletcher-Torres E; Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Alici E; Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Lund J; Hematology Center, Karolinska University Hospital, Stockholm, Sweden.
  • Nahi H; Center for Hematology and Regenerative Medicine, Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Am J Hematol ; 96(11): E443-E446, 2021 11 01.
Article in English | MEDLINE | ID: covidwho-1408309
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / Immunotherapy / Melphalan / Multiple Myeloma Topics: Vaccines Limits: Humans Language: English Journal: Am J Hematol Year: 2021 Document Type: Article Affiliation country: Ajh.26348

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / Immunotherapy / Melphalan / Multiple Myeloma Topics: Vaccines Limits: Humans Language: English Journal: Am J Hematol Year: 2021 Document Type: Article Affiliation country: Ajh.26348